Abstract
IgG4-related inflammation is a recently recognized fibro-inflammatory condition, characterized by tumefactive lesions containing dense lymphoplasmacytic infiltrates rich in IgG4+ plasma cells, storiform fibrosis, and obliterative phlebitis that are associated with elevated serum IgG4. Orbital and adnexal tissues are the fifth most common extrapancreatic site. It is mostly seen in middle-aged patients with equal involvement of men and women. IgG4-related inflammation can affect any tissue in the orbit, but the lacrimal gland (88 %) is the most commonly involved, followed by trigeminal nerve branch enlargement (39 %), extraocular enlargement (25 %), and diffuse infiltration of orbital fat (23 %). Patients usually present with a mass or mass-related symptoms and mild or no signs of inflammation. The diagnostic criteria include diffuse/localized masses in single or multiple organs, elevated serum IgG4 concentrations (≥135 mg/dl), and histopathological examination showing marked lymphocytes and plasma cell infiltration and fibrosis, with IgG4+ plasma cells comprising more than 40 % of the total plasma cell population and with at least 10 IgG4+ plasma cells per high-power microscopic field. On magnetic resonance imaging, orbital lesions are hyperintense on T1-weighted and hypointense on T2-weighted images. They enhance with gadolinium and have no destructive bony lesion. IgG4-related inflammation is thought to be a particular Th-2-mediated inflammatory response that may be initiated by particular autoantigens that become recognized during the inflammatory process. There is a delicate balance between Th-2 and Treg cells in the evolving inflammatory responses, and IgG4 behaves as a surrogate marker of a particular type of pro-fibrotic inflammatory process in which it serves to mitigate inflammatory response. IgG4-related inflammation shows a good initial response to corticosteroids, but as the disease evolves into sclerotic phase, it becomes resistant. In these cases, immunosuppressants and rituximab have been used with some success.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Stone JH, Zen V, Deshpande V. IgG4-related disease. N Engl J Med. 2012;386:539–51.
Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease. Mod Rheumatol. 2011;22:21–30.
Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732–8.
Kamisawa T, Funata N, Hayashi Y, Eishi Y, Koike M, Tsuruta K, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol. 2003;38:982–4.
Divatia M, Kim SA, Ro Y. IgG4-related sclerosing disease, an emerging entity: a review of a multi-system disease. Yonsei Med J. 2012;53:15–34.
Carruthers MN, Stone JH, Khosroshahi A. The latest on IgG4-related disease: a rapidly emerging disease. Curr Opin Rheumatol. 2012;24:60–9.
Takuma K, Kamisawa T, Anjiki H, Egawa N, Igarashi Y. Metachronous extrapancreatic lesions in autoimmune pancreatitis. Intern Med. 2010;49:529–33.
Nishimori I, Tamakoshi A, Otsuki M. Prevalence of autoimmune pancreatitis in Japan from a nationwide survey in 2002. J Gastroenterol. 2007;42:6–8.
Andrew N, Kearney D, Selva D. IgG4-related orbital disease: a meta-analysis and review. Acta Ophalmol. 2013;91:694–700.
Masaki Y, Dong L, Kurose N, et al. Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis. 2009;68:1310–5.
Khosrashahi A, Stone JH. A clinical overview of IgG4-related systemic disease. Curr Opin Rheumatol. 2011;23:57–66.
Sato Y, Ohshima K, Ichimura K, et al. Ocular adnexal IgG4-related disease has uniform clinicopathology. Pathol Int. 2008;58:465–70.
Japanese study group of IgG4-related ophthalmic disease. A prevalence study of IgG4-related ophthalmic disease in Japan. Jpn J Ophthalmol. 2013;57:573–9.
Karamchandani JR, Younes SF, Warnke RA, Natkunam Y. IgG4-related systemic sclerosing disease of the ocular adnexa: a potential mimic of ocular lymphoma. Am J Clin Pathol. 2012;137:699–711.
Wallace ZS, Deshpande V, Stone JH. Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review. Semin Arthritis Rheum. 2014;43:806–17.
Cheuk W, Yuen HK, Chan JK. Chronic sclerosing dacryoadenitis: part of the spectrum of IgG4-related sclerosing disease? Am J Surg Pathol. 2007;31:643–5.
Toyoda K, Oba H, Kutomi K, et al. MR imaging of IgG4-related disease in the head and neck and brain. AJNR Am J Neuroradiol. 2012;33:2136–9.
Matsuo T, Ichimura K, Sato Y, Tanimoto Y, Kiura K, Kanazawa S, Okada T, Yoshino T. Immunoglobulin G4 (IgG4-)-positive or –negative ocular adnexal benign lymphoid lesions in relation to systemic involvement. J Clin Exp Hematop. 2010;50:129–42.
Plaza JA, Garrity JA, Dogan A, Ananthamurthy A, Witzig TE, Salomao DR. Orbital inflammation with IgG4-positive plasma cells: manifestation of IgG4 systemic disease. Arch Ophthalmol. 2011;129:421–8.
Go H, Kim JE, Kim YA, Chung HK, Khwarg SI, Kim CW, Jeon YK. Ocular adnexal IgG4-related disease: comparative analysis with mucosa-associated lymphoid tissue lymphoma and other chronic inflammatory conditions. Histopathology. 2012;60:296–312.
Paulus YM, Cockerham KP, Cockerham GC, Gratzinger D. IgG4-positive sclerosing orbital inflammation involving the conjunctiva: a case report. Ocul Immunol Inflamm. 2012;20:375–7.
Sogabe Y, Ohshima K, Azumi A, Takahira M, Kase S, Tsuji H, Yashikawa H, Nakamura T. Location and frequency of lesions in patients with IgG4-related ophthalmic disease. Graefes Arch Clin Exp Ophthalmol. 2014;252:531–8.
Mulay K, Aggarwal E, Jariwala M, Honavar S. Orbital immunoglobulin –G4-related disease: case series and literature review. Clin Experiment Ophthalmol. 2014;42:682–7. Doi 10.111.
Hardy TG, McNabb AA, Rose GE. Enlargement of the infraorbital nerve: an important sign associated with orbital reactive lymphoid hyperplasia or immunoglobulin G4-related disease. Ophthalmology. 2014;121:1297–303.
Himi T, Takano K, Yamamoto M, et al. A novel concept of Mikulicz’s disease as IgG4-related disease. Auris Nasus Larynx. 2012;39:9–17.
Matsui S, Taki H, Shinoda K, et al. Respiratory involvement in IgG4-related Mikulicz’s disease. Mod Rheumatol. 2012;22:31–9.
Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25:1181–92.
Hamano H, Arakura N, Muraki T, Ozaki Y, Kiyosawa K, Kawa S. Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J Gastroenterol. 2006;41:1197–205.
Masaki Y, Kurose N, Yamamoto M, Takahashi H, Saeki T, Azumi A, et al. Cutoff values of serum IgG4 and histopathological IgG4+ plasma cells for diagnosis of patients with IgG4-related disease. Int J Rheumatol. 2012;2012:580814.
Yamamoto M, Tabeya T, Naishiro Y, Yajima H, Ishigami K, Shimizu Y, et al. Value of serum IgG4 in the diagnosis of IgG4-related disease and in differentiation from rheumatic disease and other diseases. Mod Rheumatol. 2012;22:419.
Ebbo M, Daniel L, Pavic M, Seve P, Hamidou M, Andres E, et al. IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registry. Medicine (Baltimore). 2012;91:49–56.
Smyrk TC. Pathological features of IgG4-related sclerosing disease. Curr Opin Rheumatol. 2011;23:74–9.
Cheuk W, Chan J. IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity. Adv Anat Pathol. 2010;17:303–32.
Zen Y, Nakanuma Y. Pathogenesis of IgG4-related disease. Curr Opin Rheumatol. 2011;23:114–8.
Okazaki K, Uchida K, Ohana M, et al. Autoimmune pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology. 2000;118:573–81.
Frulloni L, Lunardi C, Simone R, et al. Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med. 2009;381:2135–42.
Yamamoto M, Naishiro Y, Suzuki C, et al. Proteomics analysis in 28 patients with systemic IgG4-related plasmacytic syndrome. Rheumatol Int. 2010;30:565–8.
Zen Y, Fujii T, Harada K, et al. Th2 and regulatory immune reactions are increased in immunoglobulin G4-related sclerosing pancreatitis and cholangitis. Hepatology. 2007;45:1538–46.
Koyabu M, Uchida K, Miyoshi H, et al. Analysis of regulatory T cells and IgG4-positive plasma cells among patient of IgG4-related sclerosing cholangitis and autoimmune live diseases. J Gastroenterol. 2010;45:732–41.
Kanari H, Kagami S, Kashiwakuma D, et al. Role of Th2 cells in IgG4-related lacrimal gland enlargement. Int Arch Allergy Immunol. 2010;152:47–53.
Cools N, Ponsaerts P, van Tendeloo VF, et al. Regulatory T cells and human disease. Clin Dev Immunol. 2007;2007:89195.
Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol. 2004;22:531–62.
Lock RJ, Unsworth DJ. Immunoglobulins and immunoglobulin subclasses in the elderly. Ann Clin Biochem. 2003;40:143–8.
Nirula A, Glaser SM, Kalled SL, Taylor FR. What is IgG4? A review of the biology of a unique immunoglobulin subtype. Curr Opin Rheumatol. 2011;23:119–24.
Lighaam LC, Aalberse RC, Rispens T. IgG4-related fibrotic diseases from an immunological perspective: regulators out of control? Int J Rheumatol. 2012;2012:789164.
Mousallem T, Burks AW. Immunology in the clinic review series; focus on allergies: immunotherapy for food allergy. Clin Exp Immunol. 2012;167:26–31.
Yamada K, Kawano M, Inoue R, et al. Clonal relationship between infiltrating immunoglobulin G4 (IgG4)-positive plasma cells in lacrimal glands and circulating IgG4-positive lymphocytes in Mikulicz’s disease. Clin Exp Immunol. 2008;152:432–9.
Chang SY, Keogh K, Lewis J, Ryu J, Yi E. Increased IgG4-positive plasma cells in granulomatosis with polyangiitis: a diagnostic pitfall of IgG4-related disease. Int J Rheumatol. 2012;2012:121702.
Tsushima K, Yokoyama T, Kawa S, Hamano H, Tanabe T, Koizumi T, Honda T, Kawakami S, Kubo K. Elevated IgG4 levels in patients demonstrating sarcoidosis-like radiologic findings. Medicine (Baltimore). 2011;90:194–200.
Mavragani CP, Fragoulis GE, Rontogianni D, Kanariou M, Moutsopoulos HM. Elevated IgG4 serum levels among primary sjogren’s syndrome patients: do they unmask underlying IgG4-related disease? Arthritis Care Res. 2014;66:773–7.
Cheuk W, Yuen HK, Chan AC, et al. Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease. Am J Surg Pathol. 2008;32:1159–67.
Takahashi N, Ghazale AH, Smyrk TC, Mandrekar JN, Chari ST. Possible association between IgG4-associated systemic disease with or without autoimmune pancreatitis and non-Hodgkin lymphoma. Pancreas. 2009;38:523–6.
Kanda G, Ryu T, Shirai T, Ijichi M, Hishima T, Kitamura S, Bandai Y. Peripheral T-cell lymphoma that developed during the follow-up of IgG4-related disease. Intern Med. 2011;50:155–60.
Kamisawa T, Okazaki K, Kawa S, et al. Amendment of the Japanese consensus guidelines for autoimmune pancreatitis, 2013 III. Treatment and prognosis of autoimmune pancreatitis. J Gastroenterol. 2014;49:961–70.
Kubota T, Katayama M, Moritani S, Yoshino T. Serologic factors in early relapse of IgG4-related orbital inflammation after steroid treatment. Am J Ophthalmol. 2013;155:373–6.
Kim HM, Chung MJ, Chunk JB. Remission and relapse of autoimmune pancreatitis: focusing on corticosteroid treatment. Pancreas. 2010;39:555–60.
Kamisawa T, Shimosegawa T, Okazaki K, et al. Standard steroid treatment for autoimmune pancreatitis. Gut. 2009;58:1504–7.
Khosroshahi A, Stone JH. Treatment approaches to IgG4-related systemic disease. Curr Opin Rheumatol. 2011;23:67–71.
Khosroshahi A, Carruthers MN, Deshpande V, Unizony S, Bloch DB, Stone JH. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine. 2012;91:57–66.
Compliance with Ethical Requirements
Victor M. Elner and Hakan Demirci declare that they have no conflict of interest.
No human or animal studies were carried out for this article.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Elner, V.M., Demirci, H. (2015). IgG4-Related Orbital Inflammation. In: Demirci, H. (eds) Orbital Inflammatory Diseases and Their Differential Diagnosis. Essentials in Ophthalmology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-46528-8_3
Download citation
DOI: https://doi.org/10.1007/978-3-662-46528-8_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-46527-1
Online ISBN: 978-3-662-46528-8
eBook Packages: MedicineMedicine (R0)